Navigation Links
Do you own your genetic identity?
Date:3/28/2011

WHAT: Health privacy is a serious concern, but as genetic testing becomes more common, access to your genetic information raises questions the healthcare industry has never faced before. It is particularly important that we begin to address these questions now that genomic information is being collected to improve the diagnosis and treatment of children.

Experts are gathering at Children's Mercy Hospitals and Clinics to begin laying the foundation for nationwide consensus on this issue at its annual Pediatric Pharmacogenomics and Personalized Medicine Conference in Kansas City.

The conference is part of ongoing efforts of the Children's Mercy Center for Personalized Medicine and Therapeutic Innovation to apply genomic testing and clinical analytics to enhance the safety and effectiveness of medication used in children, our most vulnerable population. The center's research and clinical applications are successfully reducing adverse reactions in patients, developing genetic diagnostic tests for children, identifying medications that can cause children harm, and developing models to prevent unnecessary avoidance of medications that patients can in fact use safely.

WHEN: Wednesday, March 30 Friday, April 1, 2011


'/>"/>

Contact: Sherry Gibbs
SDGibbs@cmh.edu
816-346-1340
GolinHarris NY
Source:Eurekalert

Page: 1

Related biology news :

1. An ancestral link between genetic and environmental sex determination
2. UC Riverside geneticists to study how plants adapt to a changing environment
3. MARC Travel Awards announced for GSA 26th Fungal Genetics Meeting
4. New data published in Nature Genetics demonstrate that tiny LNA-based compounds developed by Santaris Pharma A/S inhibit entire disease-associated microRNA families
5. Vanderbilt-Ingram Cancer Center launches online genetic research tool
6. Genetic analysis reveals history, evolution of an ancient delicacy -- morels
7. New advances in genetic studies of Fanconi anemia patients
8. For first time, scientists show an HIV vaccine impacts the genetic makeup of the virus
9. Scientists discover genetic switch that increases muscle blood supply
10. Albert Einstein College of Medicine geneticist wins Sloan Research Fellowship
11. New technology pinpoints genetic differences between cancer and non-cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
Breaking Biology Technology: